Centene CNC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Centene (CNC) Business Model and Operations Summary
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Key Insights
Centene (CNC) Core Market Data and Business Metrics
Latest Closing Price
$60.45Market Cap
$29.96 BillionPrice-Earnings Ratio
9.58Total Outstanding Shares
496.04 Million SharesTotal Employees
60,500Dividend
No dividendIPO Date
December 13, 2001SIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
7700 Forsyth Blvd., St Louis, MO, 63105
Historical Stock Splits
If you bought 1 share of CNC before February 20, 2015, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| February 7, 2019 | 2-for-1 |
| February 20, 2015 | 2-for-1 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-1.05 Billion |
| Net Cash Flow | $-3.30 Billion |
| Net Cash Flow From Investing Activities | $-1.05 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-2.41 Billion |
| Net Cash Flow From Financing Activities | $-2.41 Billion |
| Exchange Gains/Losses | $8 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Current | $940 Million |
| Income Tax Expense/Benefit, Deferred | $13 Million |
| Operating Income/Loss | $3.17 Billion |
| Net Income/Loss Attributable To Parent | $3.31 Billion |
| Revenues | $163.07 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $3.44 Billion |
| Comprehensive Income/Loss Attributable To Parent | $3.45 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-11 Million |
| Other Comprehensive Income/Loss | $148 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $82.44 Billion |
| Equity | $26.50 Billion |
| Fixed Assets | $2.07 Billion |
| Redeemable Noncontrolling Interest | $10 Million |
| Long-term Debt | $18.64 Billion |
| Noncurrent Assets | $44.45 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||